patented medicine

Printer-friendly version
Pandemic showed that Canada needs a thriving biopharmaceutical industry

Government policies and regulations have created an environment hostile to research and innovation.

Printer-friendly version
Increasing barriers for drug manufacturers may ultimately hurt patients

Ottawa’s changes may delay the launch of new innovative medications in Canada.